CS
COSMOS Pharmaceutical Corporation
CSMYF · OTC
$41.20 +11.17% (+$4.14)
Market Cap ¥512.7B
P/E Ratio 15.99x
Div. Yield 1.20%
ROE 11.76%
Bulios Fair Price
$26.56
35.5% downside
Current Price
$41.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CSMYF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
78 /100
Cheap EV/EBITDA 7.77x
P/S 0.47x
P/B 1.81x
Growth
42 /100
Stable Rev. growth 9.97%
Book val. growth 10.40%
EPS growth 12.32%
Profitability
16 /100
Weak Net margin 2.91%
Op. margin 3.85%
FCF margin 1.06%
Quality
58 /100
Average ROE 11.76%
ROA 5.38%
Asset turnover 1.85x
Debt
88 /100
Low Current ratio 0.77x
Int. coverage 74.95x
Net debt/EBITDA 0.25x
Stability
61 /100
Moderate Rev. volatility 5.99%
EPS volatility 38.58%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CSMYF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Hideaki Yokoyama
Employees
5,984
Headquarters
Fukuoka City
Upcoming events
13 OCT
Earnings
Upcoming earnings report
27 NOV
Ex-Dividend
Ex-dividend date
27 NOV
Dividend Payment
Payment date
28 MAY
Ex-Dividend
Ex-dividend date
28 MAY
Dividend Payment
Payment date